Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.12335PMID 25099258PMCID PMC4137824
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of high on-treatment platelet reactivity in diabetic patients treated with aspirin.

  2014cited by this paper
• Quantitative profiling of serum samples using TMT protein labelling, fractionation and LC-MS/MS.

  2011cited by this paper
• Comparison of a protein-level and peptide-level labeling strategy for quantitative proteomics of synaptosomes using isobaric tags.

  2010cited by this paper
• Quantitative proteomic analysis of G‐protein signalling in Stagonospora nodorum using isobaric tags for relative and absolute quantification

  2010cited by this paper
• Association of Cyclooxygenase-1–Dependent and –Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac Catheterization

  2009cited by this paper
• Clinical Utility of the PFA-100

  2008cited by this paper
• Letter by Klein Regarding Article, "Evaluation of Dose-Related Effects of Aspirin on Platelet Function: Results From the Aspirin-Induced Platelet Effect (ASPECT) Study"

  2008cited by this paper
• 8‐Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

  2007cited by this paper
• Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review.

  2007cited by this paper
• Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study.

  2007cited by this paper
• Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein.

  2007cited by this paper
• The genetics of aspirin resistance

  2007cited by this paper
• A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.

  2007cited by this paper
• Current options in platelet function testing.

  2006cited by this paper
• Biological effects of aspirin and clopidogrel in a randomized cross‐over study in 96 healthy volunteers

  2006cited by this paper
• Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.

  2006cited by this paper
• Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease

  2006cited by this paper
• Platelet function analyzer (PFA)‐100® closure time in the evaluation of platelet disorders and platelet function

  2006cited by this paper
• Aspirin resistance.

  2006cited by this paper
• Low-dose aspirin increases aspirin resistance in patients with coronary artery disease.

  2005cited by this paper
• Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S

  2004cited by this paper
• Aspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance

  2004cited by this paper
• Aspirin resistance

  2004cited by this paper
• Interleukin-7–Mediated Inflammation in Unstable Angina: Possible Role of Chemokines and Platelets

  2003cited by this paper
• Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS.

  2003cited by this paper
• Scientific and therapeutic advances in antiplatelet therapy

  2003cited by this paper
• Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms.

  2003cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Aspirin Resistance in Cardiovascular Disease: A Review of Prevalence, Mechanisms, and Clinical Significance

  2002cited by this paper
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

  2001cited by this paper
• Rapid platelet-function assay: an automated and quantitative cartridge-based method.

  1999cited by this paper
• Preliminary Data from a Field Trial of the PFA-100™ System

  1995cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients

  1994cited by this paper
• Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

  1988cited by this paper
• Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

  1988cited by this paper
• Acetylation of prostaglandin synthase by aspirin.

  1975cited by this paper
• The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.

  1975cited by this paper
• HL-A AND INFECTIVE SACROILEITIS

  1974cited by this paper
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

  1962cited by this paper

• Proteomic aspects of antiplatelet therapy resistance: mechanisms, biomarkers, and prospects for personalized treatment (review)

  2026cites this paper
• Safety and efficacy of aspirin after combined cerebral revascularization for ischemic moyamoya disease: A prospective study

  2023cites this paper
• The effect of clopidogrel and aspirin on the severity of traumatic brain injury in a rat model.

  2022cites this paper
• Platelets disrupt vasculogenic mimicry by cancer cells

  2020cites this paper
• Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race.

  2020cites this paper
• Prevalence rate of laboratory defined aspirin resistance in cardiovascular disease patients: A systematic review and meta-analysis

  2020cites this paper
• The Platelet Proteome

  2019cites this paper
• Not all (N)SAID and done: Effects of nonsteroidal anti‐inflammatory drugs and paracetamol intake on platelets

  2019cites this paper
• Proteomics in Vascular Biology

  2019cites this paper
• Aspirin-Dependent Effects on Purinergic P2Y1 Receptor Expression

  2019cites this paper
• Anti-inflammatory effects of anti-platelet drugs : implications for atherosclerosis

  2018cites this paper
• Hypoxia and Ischemia Promote a Maladaptive Platelet Phenotype

  2018cites this paper
• Platelet Proteomics and its Applications to Study Platelet-Related Disorders

  2017cites this paper
• Suspected aspirin resistance in individual healthy adult warmblood horses

  2017cites this paper
• The effect of aspirin on circulating netrin-1 levels in humans is dependent on the inflammatory status of the vascular endothelium

  2017cites this paper
• Platelet Carbonic Anhydrase II, a Forgotten Enzyme, May Be Responsible for Aspirin Resistance

  2017influential citation
• Enhanced platelet MRP4 expression and correlation with platelet function in patients under chronic aspirin treatment

  2016cites this paper
• Platelets as Biomarkers of Coronary Artery Disease

  2016cites this paper
• Aspirin resistance in coronary heart disease: Current understandings and strategies

  2016cites this paper
• Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets.

  2016cites this paper
• Platelet proteomics applied to the search for novel antiplatelet therapeutic targets

  2016cites this paper
• Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment

  2016cites this paper
• Antiplatelet drug resistance: Molecular insights and clinical implications.

  2015cites this paper
• Aspirin influences megakaryocytic gene expression leading to up-regulation of multidrug resistance protein-4 in human platelets

  2014cites this paper
• Platelets: Still a Therapeutical Target for Haemostatic Disorders

  2014cites this paper